Caricamento...
Non-vitamin K Antagonist Oral Anticoagulant After Acute Coronary Syndrome: Is There a Role?
Despite dual antiplatelet therapy (DAPT) including potent P2Y12 inhibitors, recurrent ischaemic events occur in a significant number of patients after acute coronary syndrome (ACS), warranting new antithrombotic strategies. Combinations of non-vitamin K antagonist oral anticoagulant (NOAC) with anti...
Salvato in:
| Pubblicato in: | Interv Cardiol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Radcliffe Cardiology
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5980653/ https://ncbi.nlm.nih.gov/pubmed/29928315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/icr.2018:5:2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|